Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:19 PM
Ignite Modification Date:
2025-12-24 @ 9:19 PM
NCT ID:
NCT04916704
Eligibility Criteria:
Inclusion Criteria:
* New diagnosis of AAV as evidenced by relevant biopsy and / or clinical diagnosis in the context of a positive ANCA antibody OR major relapse of previously diagnosed AAV that requires re-induction of remission treatment with intravenous rituximab or cyclophosphamide together with high dose oral corticosteroids
* Age \>18 years
* Willingness to participate in the study and attend clinic and study visits
* Able to provide written informed consent
Exclusion Criteria:
* Strong suspicion of alternative diagnosis other than AAV
* Subjects who do not have capacity to consent to study participation as defined by the Mental Capacity Act 2005
* Inability or unwillingness to attend study visits
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04916704
Study Brief:
Protocol Section:
NCT04916704